natgillin/translations-raw huggingface dataset:
26 If necessary, NovoRapid may also be administered intravenously (see section 6.6) which should be carried out by health care professionals.
28 Če je potrebno, je mogoče NovoRapid aplicirati tudi intravensko (glejte poglavje 6. 6), vendar ga sme tako uporabiti samo zdravnik.
For example, in the timing of the injections in relation to meals.
Pri otrocih sme imeti NovoRapid prednost pred topnim humanim insulinom, če bi bil hiter začetek delovanja lahko koristen (glejte poglavji 5. 2 in 5. 2), npr. pri časovnem usklajevanju injekcij glede na obroke.
FlexPen are pre-filled pens designed to be used with NovoFine short cap needles.
FlexPen je napolnjen injekcijski peresnik, namenjen za uporabo z iglami NovoFine s kratkim pokrovčkom.
The needle box is marked with an S.
Škatla z iglami je označena s S.
Detailed instruction accompanying the device must be followed.
Upoštevati je treba podrobna navodila, priložena peresniku.
27 Transferring a patient to a new type or brand of insulin should be done under strict medical supervision.
29 Prehod bolnika na novo vrsto ali znamko insulina mora potekati pod strogim zdravniškim nadzorom.
Patients taking NovoRapid may require an increased number of daily injections or a change in dosage from that used with their usual insulins.
Bolniki, ki uporabljajo NovoRapid, utegnejo potrebovati večje število dnevnih injekcij ali drugačen odmerek kot med uporabo svojih običajnih insulinov.
28 Patients should be advised to take precautions in order to avoid hypoglycaemia whilst driving.
30 Bolnikom je treba svetovati, naj upoštevajo ustrezne previdnostne ukrepe, da bi se izognili hipoglikemiji med upravljanjem vozila.
These symptoms are usually of transitory nature.
31 Splošne težave in spremembe na mestu aplikacije Občasno - edemi Po začetku zdravljenja z insulinom se lahko pojavijo edemi, ki so ponavadi prehodni.
The blood glucose lowering effect of insulin occurs when the molecules facilitate the uptake of glucose by binding to insulin receptors on muscle and fat cells - and simultaneously inhibit the output of glucose from the liver.
Učinek insulina na znižanje glukoze v krvi, je posledica lažjega privzema glukoze zaradi vezave insulina na insulinske receptorje na mišičnih in maščobnih celicah ter hkratne inhibicije sproščanja glukoze iz jeter.
30 When NovoRapid is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.
32 NovoRapid začne delovati v 10 do 20 minutah po subkutani injekciji.
Adults.
Odrasli.
0.03; 0.22] percentage points and by 0.15 [95% C. I.
884 bolnikov, je NovoRapid v primerjavi s humanim insulinom znižal glikirani hemoglobin za 0, 12 [95% interval zaupanja 0, 03; 0, 22] oz.
Insulin aspart was rapidly absorbed in both age groups, with similar tmax as in adults.
Cmax pa se je med
However, Cmax differed between the age groups, stressing the importance of the individual titration of NovoRapid.
33 starostnima skupinama razlikovala, kar poudarja pomembnost individualnega titriranja zdravila NovoRapid.
31 Elderly:
Starejši:
Glycerol Phenol Metacresol Zinc chloride Disodium phosphate dihydrate Sodium chloride Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections
glicerol fenol metakrezol cinkov klorid natrijev hidrogenfosfat dihidrat natrijev klorid klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavo pH) voda za injekcije
The in-use shelf life is 4 weeks.
6. 4 Posebna navodila za shranjevanje
Keep the cap on when NovoRapid FlexPen is not in use in order to protect from light.
Kadar NovoRapid FlexPen ni v uporabi, naj bo za zaščito pred svetlobo pokrit s pokrovčkom!
NovoRapid FlexPen in use or carried as a spare:
NovoRapid FlexPen, ki je v uporabi ali ga ima bolnik pri sebi za rezervo:
Cartons of 1, 5 or 10 pre-filled pens.
Škatlice z 1, 5 ali 10 napolnjenimi injekcijskimi peresniki.
NovoRapid FlexPen should only be used in combination with products that are compatible with them and allow the pens to function safely and effectively.
Peresnike NovoRapid FlexPen se sme uporabljati samo z izdelki, s katerimi so kompatibilni in ki omogočajo varno in učinkovito delovanje teh peresnikov.
NovoRapid FlexPen is for use by one person only.
NovoRapid FlexPen je namenjen uporabi ene same osebe.
NovoRapid FlexPen must not be refilled.
Peresnikov NovoRapid FlexPen se ne sme znova polniti.
NovoFine S needles are designed to be used with NovoRapid FlexPen.
Za uporabo s peresnikom NovoRapid FlexPen so namenjene igle NovoFine S.
NovoRapid InnoLet 100 U/ ml, solution for injection in a pre-filled pen.
NovoRapid InnoLet 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
As with all insulins the duration of action will vary according to the dose, injection site, blood flow, temperature and the level of physical activity.
Tako kot pri vseh insulinih je trajanje delovanja spremenljivo, odvisno od odmerka, injekcijskega mesta, krvnega pretoka, temperature in stopnje telesne dejavnosti.
35 If necessary, NovoRapid may also be administered intravenously (see section 6.6) which should be carried out by health care professionals.
37 Če je potrebno, je mogoče NovoRapid aplicirati tudi intravensko (glejte poglavje 6. 6), vendar ga sme tako aplicirati samo zdravnik.
NovoRapid may be used for Continuous Subcutaneous Insulin Infusion (CSII) in pump systems suitable for insulin infusion.
NovoRapid se lahko uporablja za kontinuirano subkutano infundiranje insulina (CSII – Continuous Subcutaneous Insulin Infusion) v sistemih s črpalko, primernih za infundiranje insulina.
InnoLet are pre-filled pens designed to be used with NovoFine short cap needles.
InnoLet so napolnjen injekcijski peresniki, namenjeni za uporabo z iglami NovoFine s kratkim pokrovčkom.
36 Transferring a patient to a new type or brand of insulin should be done under strict medical supervision.
38 Prehod bolnika na novo vrsto ali znamko insulina mora potekati pod strogim zdravniškim nadzorom.
Changes in strength, brand, type, species (animal, human, human insulin analogue) and/ or method of manufacture may result in a change in dosage.
Spremembe v jakosti, znamki, vrsti, izvoru (živalski, humani, analog humanega insulina) in/ ali načinu izdelave insulina imajo lahko za posledico spremembo odmerjanja.
37 4.7 Effects on ability to drive and use machines
4. 7 Vpliv na sposobnost vožnje in upravljanja s stroji
Patients should be advised to take precautions in order to avoid hypoglycaemia whilst driving.
39 Bolnikom je treba svetovati, naj upoštevajo ustrezne previdnostne ukrepe, da bi se izognili hipoglikemiji med upravljanjem vozila.
38 Uncommon - Local hypersensitivity Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin.
Občasno - lokalna preobčutljivost Med zdravljenjem z insulinom se lahko pojavijo lokalne preobčutljivostne reakcije (pordelost, oteklina in srbenje na mestu injiciranja).
These symptoms are usually of transitory nature.
40 Splošne težave in spremembe na mestu aplikacije Občasno - edemi Po začetku zdravljenja z insulinom se lahko pojavijo edemi, ki so ponavadi prehodni.
39 Blood glucose (mmol/ l)
Po subkutani injekciji je delovanje zdravila NovoRapid kratkotrajnejše kot delovanje topnega humanega insulina. glukoza v krvi (mmol/ l
When NovoRapid is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.
41 NovoRapid začne delovati v 10 do 20 minutah po subkutani injekciji.
However, Cmax differed between the age groups, stressing the importance of the individual titration of NovoRapid.
42 starostnima skupinama razlikovala, kar poudarja pomembnost individualnega titriranja zdravila NovoRapid.
Keep the cap on when NovoRapid InnoLet is not in use in order to protect from light.
Kadar NovoRapid ni v uporabi, naj bo za zaščito pred svetlobo pokrit s pokrovčkom!
NovoRapid InnoLet in use or carried as a spare:
NovoRapid InnoLet, ki je v uporabi ali ga ima bolnik pri sebi za rezervo:
NovoRapid InnoLet should only be used in combination with products that are compatible with them and allow the pens to function safely and effectively.
Peresnike NovoRapid InnoLet se sme uporabljati samo z izdelki, s katerimi so kompatibilni in ki omogočajo varno in učinkovito delovanje teh peresnikov.
NovoRapid InnoLet is for use by one person only.
NovoRapid InnoLet je namenjen uporabi ene same osebe.
NovoRapid InnoLet must not be refilled.
Peresnikov NovoRapid InnoLet se ne sme znova polniti.
NovoFine S needles are designed to be used with NovoRapid InnoLet.
Za uporabo s peresnikom NovoRapid InnoLet so namenjene igle NovoFine S.
For intravenous use, infusion systems with NovoRapid 100 U/ ml at concentrations from 0.05 U/ ml to 1.0 U/ ml insulin aspart in the infusion fluids 0.9% sodium chloride, 5% dextrose or 10% dextrose
Infuzijski sistemi za intravensko infundiranje z zdravilom NovoRapid 100 e. / ml v koncentraciji od 0, 05 do 1, 0 e. / ml insulina aspart v infuzijskih tekočinah 0, 9% raztopine natrijevega klorida, 5% raztopine glukoze ali 10% raztopine glukoze, vključno s 40 mmol/ l raztopine kalijevega klorida, z uporabo polipropilenskih infuzijskih vrečk so pri sobni temperaturi stabilni 24 ur.
43 ANNEX II
45 DODATEK II
NovoRapid Vial, NovoLet and InnoLet:
NovoRapid Viala, NovoLet in InnoLet:
47 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
47 DODATEK III
OUTER CARTON
49 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid 100 U/ ml Solution for injection in a vial Insulin aspart
NovoRapid 100 e. / ml raztopina za injiciranje v viali insulin aspart
1 ml solution contains 100 U (3.5 mg) of insulin aspart (r-DNA),
(3, 5 mg) insulina aspart (r- DNA),
glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections
glicerol, fenol, metakrezol, cinkov klorid, natrijev hidrogenfosfat dihidrat, natrijev klorid, klorovodikovo kislino, natrijev hidroksid in vodo za injekcije.
Subcutaneous or intravenous use Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
EXP/
Uporabno do /
Store in a refrigerator (2°C – 8°C) Do not freeze Keep the vial in the outer carton During use: use within 4 weeks Do not refrigerate or store above 30°C
Ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
Medicinal product subject to medical prescription
Zdravilo se izdaja le na recept..
49 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
51 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections
glicerol, fenol, metakrezol, cinkov klorid, natrijev hidrogenfosfat dihidrat natrijev klorid, klorovodikovo kislino, natrijev hidroksid in vodo za injekcije.
Medicinal product subject to medical prescription
Zdravilo se izdaja le na recept.
51 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
53 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
1 x 10 ml This is part of a multipack and not for sale of individual vials
1 x 10 ml To je del pakiranja z več vialami in ni namenjeno za izdajanje posameznih vial.
53 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
55 PODATKI NA NALEPKI ZUNANJEGA OVOJA SKUPNIH PAKIRANJ, OVITIH V PROSOJNO FOLIJO
5 x (1 x 10 ml) This is a multipack and not for sale of individual vials
5 x (1 x 10 ml) To pakiranje z več vialami ni namenjeno za izdajanje posameznih vial.
55 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
57 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH NALEPKA
NovoRapid 100 U/ ml Solution for injection Insulin aspart SC, IV use
NovoRapid 100 e. / ml raztopina za injiciranje v viali insulin aspart Za s. c., i. v. uporabo.
56 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
58 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid Penfill 100 U/ ml Solution for injection in a cartridge Insulin aspart
NovoRapid Penfill 100 e. / ml raztopina za injiciranje v injekcijskem vložku insulin aspart
Subcutaneous or intravenous use NovoRapid Penfill is for use with Novo Nordisk insulin devices Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
NovoRapid Penfill is for use by one person only
Injekcijski vložek Penfill je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C – 8°C) Do not freeze Keep the cartridge in the outer carton During use: use within 4 weeks Do not refrigerate or store above 30°C
Ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
58 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
60 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid Penfill is for use by one person only
NovoRapid Penfill je namenjen uporabi ene same osebe.
60 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
62 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH NALEPKA
NovoRapid Penfill 100 U/ ml Solution for injection Insulin aspart SC, IV use
NovoRapid Penfill 100 e. / ml raztopina za injiciranje v injekcijskem vložku insulin aspart Za s. c., i. v. uporabo.
61 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
63 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid NovoLet 100 U/ ml Solution for injection in a pre-filled pen Insulin aspart
NovoRapid NovoLet 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart
Subcutaneous use NovoRapid NovoLet is designed to be used with NovoFine needles NovoFine needles are not included Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
NovoRapid NovoLet is for use by one person only
NovoRapid NovoLet je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C – 8°C) Do not freeze Protect from light During use: use within 4 weeks Do not refrigerate or store above 30°C
Ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
63 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE OUTER PACKAGING
65 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
65 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
67 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH NALEPKA
NovoRapid NovoLet 100 U/ ml Solution for injection Insulin aspart SC use
NovoRapid NovoLet 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart Za s. c. uporabo.
66 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE OUTER PACKAGING
68 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid FlexPen 100 U/ ml Solution for injection in a pre-filled pen Insulin aspart
NovoRapid FlexPen 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart
Subcutaneous use Designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm Needles are not included Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
NovoRapid FlexPen is for use by one person only
NovoRapid FlexPen je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C – 8°C) Do not freeze Protect from light During use: use within 4 weeks Do not refrigerate or store above 30°C
Ne shranjujte v hladilniku ali pri temperaturi nad 30 C!
68 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
70 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
70 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
72 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
72 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
74 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH NALEPKA
NovoRapid FlexPen 100 U/ ml Solution for injection Insulin aspart SC use
NovoRapid FlexPen 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart Za s. c. uporabo.
73 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
75 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
NovoRapid InnoLet 100 U/ ml Solution for injection in a pre-filled pen Insulin aspart
NovoRapid InnoLet 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart
Subcutaneous use NovoRapid InnoLet is designed to be used with NovoFine S needles NovoFine S needles are not included Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
NovoRapid InnoLet is for use by one person only
NovoRapid InnoLet je namenjen uporabi ene same osebe.
75 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
77 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
77 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
79 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ŠKATLA
Store in a refrigerator (2°C – 8°C) Do not freeze Protect from light During use: use within 4 weeks Do not refrigerate or store above 30°C
Ne shranjujte v hladilniku ali pri temperaturi nad 3 °C!
79 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
81 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH NALEPKA
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION
IME ZDRAVILA IN, ČE JE POTREBNO, POT( I) UPORABE
NovoRapid InnoLet 100 U/ ml Solution for injection Insulin aspart SC use
NovoRapid InnoLet 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin aspart Za s. c. uporabo.
80 B.
82 B.
INFORMATION FOR THE USER
83 NAVODILO ZA UPORABO
NovoRapid 100 U/ ml solution for injection in a vial insulin aspart
NovoRapid 100 e. / ml raztopina za injiciranje v viali insulin aspart
Do not pass it on to others.
Morda ga boste želeli ponovno prebrati. – Če imate dodatna vprašanja, se posvetujte z zdravnikom, z diabetološko sestro ali s farmacevtom. – Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
It may harm them, even if their symptoms are the same as yours – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist.
Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim. – Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
WHAT NOVORAPID IS AND WHAT IT IS USED FOR
KAJ JE ZDRAVILO NOVORAPID IN ZA KAJ GA UPORABLJAMO
NovoRapid is an insulin analogue to treat diabetes.
NovoRapid je insulinski analog za zdravljenje diabetesa.
It comes in a 10 ml vial that you use to fill a syringe.
Na voljo je v 10- ml viali, ki se uporablja za polnjenje brizge.
NovoRapid is a rapid-acting insulin for use in adults and children from 2 years of age.
NovoRapid je hitrodelujoč insulin namenjen uporabi pri odraslih in otrocih starejših od 2 let.
It will start to lower your blood sugar 10– 20 minutes after you take it, a maximum effect occurs between 1 and 3 hours and the effect lasts for 3– 5 hours.
To pomeni, da začne sladkor v krvi zniževati v 10 do 20 minutah po uporabi, doseže največji učinek v 1 do 3 urah in deluje od 3 do 5 ur.
Due to this short action NovoRapid should normally be taken in combination with intermediate-acting or long-acting insulin preparations.
Zaradi njegovega kratkega delovanja je treba NovoRapid praviloma uporabljati v kombinaciji s srednje ali dolgodelujočimi insulini.
BEFORE YOU USE NOVORAPID
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO NOVORAPID
Do not use NovoRapid
Ne uporabljajte zdravila NovoRapid:
► If you are allergic (hypersensitive) to insulin aspart, metacresol or any of the other ingredients (see 7 Further information).
če ste alergični na (preobčutljivi za) insulin aspart, metakrezol ali katero koli sestavino ► zdravila (glejte okvir levo spodaj).
Look out for the signs of allergy in 5 Possible side effects ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is symptoms of low blood sugar).
Možni neželeni učinki; če čutite, da se pojavlja hipa (hipa je okrajšava za hipoglikemično reakcijo in pomeni ► simptome nizkega sladkorja v krvi).
Take special care with NovoRapid
Bodite posebno pozorni pri uporabi zdravila NovoRapid
► If you have trouble with your kidneys or liver, your doctor may decide to alter your insulin dose ► If you are drinking alcohol (also beer and wine): watch for signs of a hypo and never drink alcohol on an empty stomach ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin.
Če ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo običajno prehrano. ► Če ste bolni: insulin uporabljajte še naprej.
Your need for insulin may change ► If you have an infection, fever or an operation you may need more insulin than usual ► If you suffer from diarrhoea, vomiting or eat less than usual you may also need less insulin than usual ► If you are going abroad: travelling over time zones may affect your insulin needs and the timing of the injections.
Če potujete v tujino: potovanje med različnimi časovnimi pasovi lahko vpliva na potrebe po ► insulinu in časovni razpored injekcij.
Consult your doctor if you are planning such travelling.
Če načrtujete tako potovanje, se posvetujte s svojim zdravnikom.
Using other medicines Many medicines affect the way glucose works in your body and this may influence your insulin dose.
Uporaba drugih zdravil Številna zdravila vplivajo na delovanje glukoze v telesu in lahko tako vplivajo na vaš odmerek insulina.
Your need for insulin may change if you also take:
Posvetujte se s svojim zdravnikom ali farmacevtom, če jemljete ali ste pred kratkim jemali katero koli zdravilo, tudi če ste ga dobili brez recepta.
82 (except topical administration), oral contraceptives, thiazides, thyroid hormones, sympathomimetics, danazol, octreotide and sulphonamides.
84 Vaša potreba po insulinu se lahko spremeni, če uporabljate tudi: peroralne antidiabetike, zaviralce monoaminooksidaze (MAOI), zaviralce beta, zaviralce angiotenzinske konvertaze (ACE), salicilate, anabolne steroide in glukokortikoide (razen za lokalno uporabo), kontracepcijske tablete, tiazide, ščitnične hormone, simpatikomimetike, danazol, oktreotid in sulfonamide.
Pregnancy and breast-feeding If you are planning a pregnancy or if you are pregnant or breast-feeding: please contact your doctor for advice.
Nosečnost in dojenje Če nameravate zanositi, ste noseči ali če dojite: za nasvet prosite zdravnika.
NovoRapid can be used during pregnancy.
NovoRapid lahko uporabljate med nosečnostjo.
Your insulin dosage may need to be changed during pregnancy and after delivery.
Med nosečnostjo in porodu bo vaše odmerjanje insulina morda treba spremeniti.
Careful control of your diabetes, and prevention of hypoglycaemia, is important, also for the health of your baby.
Natančna urejenost vaše sladkorne bolezni in preprečevanje hipoglikemij sta pomembna, tudi za zdravje vašega otroka.
Driving and using machines If you drive or use tools or machines: your ability to concentrate or react may be reduced if you have a hypo.
Vpliv na sposobnost upravljanja vozil in strojev Če vozite ali uporabljate orodje ali stroje: vaša sposobnost za koncentracijo ali reagiranje se med hipo zmanjša.
You should contact your doctor about the advisability of driving if you have frequent episodes of hypos or reduced or absent warning signs of hypos.
Z zdravnikom se posvetujte, ali naj sploh vozite ali upravljate s stroji, če doživljate veliko hip ali hipe težko prepoznate.
NovoRapid has a rapid onset of effect therefore if hypoglycaemia occurs, you may experience it earlier after an injection when compared to soluble insulin human.
Če se pojavi hipoglikemija, jo boste zato najbrž občutili prej po injekciji kot po topnem humanem insulinu.
There is no clinical experience with NovoRapid in children under the age of 2 years.
Pri otrocih do 2. leta starosti ni kliničnih izkušenj z zdravilom NovoRapid.